Prevalence and Incidence of Uveitis in Korean Patients with Sarcoidosis: A Population-Based Study.

IF 2.6 4区 医学 Q2 OPHTHALMOLOGY
Daehwan Shin, Seongho Kim, Mingui Kong, Bo Hee Kim, Su Jeong Song
{"title":"Prevalence and Incidence of Uveitis in Korean Patients with Sarcoidosis: A Population-Based Study.","authors":"Daehwan Shin, Seongho Kim, Mingui Kong, Bo Hee Kim, Su Jeong Song","doi":"10.1080/09273948.2024.2430708","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Sarcoidosis is a systemic granulomatous inflammatory disease with varying clinical presentations, including sarcoid uveitis, which is the most prevalent ocular manifestation of sarcoidosis and differs by region and ethnicity. This study aims to determine the incidence and prevalence of sarcoidosis-related uveitis in South Korea, providing essential epidemiological data.</p><p><strong>Methods: </strong>This nationwide, population-based retrospective study used the Korean Health Insurance Review and Assessment database from 2010 to 2019. It included all individuals diagnosed with sarcoidosis (ICD-10 code D86) and focused on those with newly developed uveitis. We assessed annual incidence, prevalence, gender-specific trends, age at diagnosis, treatment patterns, and recurrence. Cases were categorized as single episode or recurrent/chronic based on treatment duration and interval before recurrence.</p><p><strong>Results: </strong>Among 9,485 patients with sarcoidosis, 2,730 (28.8%) had sarcoidosis-related uveitis, with 2,413 (88.4%) being recurrent/chronic. Anterior uveitis was the most common presentation (78.0%), with posterior segment involvement in 22.0% of cases. The peak age of onset was 50-59 years for both genders. The incidence rate was 0.33 and 0.64 per 100,000 for men and women, respectively. The prevalence was 0.18 and 0.35 per 100,000 for men and women, respectively. Among sarcoidosis patients, 32.9% with uveitis used three or more combinations of systemic steroids and immunosuppressants, compared to 11.1% without uveitis.</p><p><strong>Conclusion: </strong>The high prevalence of sarcoid uveitis in sarcoidosis patients necessitates regular ophthalmic examinations. Our findings highlight the need for comprehensive eye care in managing sarcoidosis and suggest that uveitis may increase disease severity, warranting tailored treatment and enhanced monitoring protocols in Korea.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"1-6"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2024.2430708","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Sarcoidosis is a systemic granulomatous inflammatory disease with varying clinical presentations, including sarcoid uveitis, which is the most prevalent ocular manifestation of sarcoidosis and differs by region and ethnicity. This study aims to determine the incidence and prevalence of sarcoidosis-related uveitis in South Korea, providing essential epidemiological data.

Methods: This nationwide, population-based retrospective study used the Korean Health Insurance Review and Assessment database from 2010 to 2019. It included all individuals diagnosed with sarcoidosis (ICD-10 code D86) and focused on those with newly developed uveitis. We assessed annual incidence, prevalence, gender-specific trends, age at diagnosis, treatment patterns, and recurrence. Cases were categorized as single episode or recurrent/chronic based on treatment duration and interval before recurrence.

Results: Among 9,485 patients with sarcoidosis, 2,730 (28.8%) had sarcoidosis-related uveitis, with 2,413 (88.4%) being recurrent/chronic. Anterior uveitis was the most common presentation (78.0%), with posterior segment involvement in 22.0% of cases. The peak age of onset was 50-59 years for both genders. The incidence rate was 0.33 and 0.64 per 100,000 for men and women, respectively. The prevalence was 0.18 and 0.35 per 100,000 for men and women, respectively. Among sarcoidosis patients, 32.9% with uveitis used three or more combinations of systemic steroids and immunosuppressants, compared to 11.1% without uveitis.

Conclusion: The high prevalence of sarcoid uveitis in sarcoidosis patients necessitates regular ophthalmic examinations. Our findings highlight the need for comprehensive eye care in managing sarcoidosis and suggest that uveitis may increase disease severity, warranting tailored treatment and enhanced monitoring protocols in Korea.

韩国肉样瘤病患者葡萄膜炎的患病率和发病率:基于人群的研究
目的:肉样瘤病是一种全身性肉芽肿炎症性疾病,临床表现各不相同,其中包括肉样瘤葡萄膜炎,它是肉样瘤病最常见的眼部表现,因地区和种族而异。本研究旨在确定肉样瘤病相关葡萄膜炎在韩国的发病率和流行率,从而提供重要的流行病学数据:这项基于人口的全国性回顾性研究使用了 2010 年至 2019 年韩国健康保险审查和评估数据库。研究对象包括所有确诊为肉样瘤病(ICD-10代码D86)的患者,重点关注新发葡萄膜炎患者。我们评估了年度发病率、流行率、性别特异性趋势、诊断年龄、治疗模式和复发情况。根据治疗持续时间和复发前的间隔时间,将病例分为单发和复发/慢性病例:在9485名肉样瘤病患者中,2730人(28.8%)患有与肉样瘤相关的葡萄膜炎,其中2413人(88.4%)为复发性/慢性葡萄膜炎。前葡萄膜炎是最常见的表现(78.0%),22.0%的病例后段受累。男女发病高峰年龄均为 50-59 岁。男性和女性的发病率分别为每 10 万人 0.33 例和 0.64 例。男性和女性的发病率分别为每 10 万人 0.18 例和 0.35 例。在肉样瘤病患者中,32.9%的葡萄膜炎患者使用了三种或三种以上的全身性类固醇和免疫抑制剂,而没有葡萄膜炎的患者仅为11.1%:结论:肉样葡萄膜炎在肉样瘤病患者中的发病率很高,因此有必要定期进行眼科检查。我们的研究结果表明,在治疗肉样瘤病时需要进行全面的眼科护理,葡萄膜炎可能会增加疾病的严重程度,因此在韩国需要采取针对性的治疗和加强监测方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信